5. Developing a vaccine

[Coronavirus image courtesy of World Health Organization]
Johnson & Johnson (NYSE:JNJ) announced on March 13 that its Janssen Pharmaceutical Cos. has forged a partnership with the Beth Israel Deaconess Medical Center (BIDMC) to support coronavirus vaccine development. The goal is to start a Phase 1 clinical study of a potential vaccine candidate by the end of the year.